Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report

BACKGROUND: Convalescent plasma (CP) transfusion was reported to be effective in treating critically ill patients with COVID-19, and hydroxychloroquine could potently inhibit SARS-CoV-2 in vitro. Herein, we reported a case receiving combination therapy with CP transfusion and hydroxychloroquine for...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tian-min, Lin, Bin, Chen, Cong, Liu, Long-gen, Xue, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303939/
https://www.ncbi.nlm.nih.gov/pubmed/32560646
http://dx.doi.org/10.1186/s12985-020-01354-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303939/
https://www.ncbi.nlm.nih.gov/pubmed/32560646
http://dx.doi.org/10.1186/s12985-020-01354-6

Ejemplares similares